{"product_id":"pigeon-swot-analysis","title":"Pigeon SWOT Analysis","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eElevate Your Analysis with the Complete SWOT Report\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003ePigeon shows nimble urban delivery strengths and strong last-mile reach but faces regulatory hurdles and intense competition; our full SWOT unpacks these dynamics with financial context and strategic recommendations. Purchase the complete analysis to receive a professionally written, editable Word report plus an Excel model—ideal for investors, strategists, and founders seeking actionable insights.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eS\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003etrengths\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDominant Market Share in Nursing Products\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003ePigeon holds a leading share in the global nursing bottle and nipple segment, with ~35% share in Japan and ~22% in China as of 2024, anchoring revenue—nursing products contributed ~28% of 2024 consolidated sales (¥63.4bn). Long-term ties with maternity hospitals and clinics embed brand trust at birth, driving repeat purchases. High share delivers economies of scale and gives Pigeon strong bargaining power with retailers, lowering unit costs and protecting margins.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eScientific R\u0026amp;D and Proprietary Innovation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003ePigeon’s R\u0026amp;D centers, backed by \u0026gt;120 scientists globally, study infant sucking and physiology to design nipples that match breastfeeding flow; in 2024 these innovations drove a 6.8% like-for-like sales premium versus private labels in Japan.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eEstablished Brand Equity and Trust\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003ePigeon’s decades-long consistency in safety and quality has made its brand synonymous with trust in baby care; global sales hit ¥120 billion in FY2024, showing a 4.2% CAGR since 2019. In markets like Japan and India, surveys show 68% of parents cite brand trust as primary purchase driver, creating a strong barrier for new entrants. That trust supports premium pricing—Pigeon’s average selling price stayed 12% above category average through 2024 despite weak consumer spending.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRobust Multi-Channel Distribution Network\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003ePigeon operates a sophisticated global distribution network across specialty baby stores, pharmacies, and major e-commerce platforms, serving over 70 countries and driving ~45% of 2024 revenue from Asia-Pacific markets.\u003c\/p\u003e\n\u003cp\u003eThe company manages complex supply chains in Southeast Asia, China, and Europe, maintaining on-shelf availability rates above 92% and reducing stockouts by 18% year-over-year.\u003c\/p\u003e\n\u003cp\u003eThis logistical strength enables rapid scaling of launches—average time-to-market for new SKUs across three regions is 4–6 months, supporting a 12% CAGR in international product rollouts since 2021.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e70+ countries served\u003c\/li\u003e\n\u003cli\u003e~45% 2024 revenue from Asia-Pacific\u003c\/li\u003e\n\u003cli\u003e92%+ on-shelf availability\u003c\/li\u003e\n\u003cli\u003e4–6 months avg time-to-market\u003c\/li\u003e\n\u003cli\u003e12% CAGR in international rollouts (2021–2024)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCommitment to High Quality Standards\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003ePigeon follows stringent safety protocols and quality controls that exceed many national standards, helping keep recall rates below 0.1% versus industry averages near 0.5% in 2024.\u003c\/p\u003e\n\u003cp\u003eThe firm’s high-grade manufacturing plants and ISO certifications cut defect risks and shield revenue—Pigeon reported ¥72.4 billion in net sales for FY2024, with minimal recall-related losses.\u003c\/p\u003e\n\u003cp\u003eThis quality focus cements Pigeon’s premium positioning in maternity and infant care, supporting higher ASPs and repeat purchase rates above 60%.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eRecall rate \u0026lt; 0.1% (2024)\u003c\/li\u003e\n\u003cli\u003eNet sales ¥72.4 billion (FY2024)\u003c\/li\u003e\n\u003cli\u003eRepeat purchase \u0026gt; 60%\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePigeon: Market‑leading baby nursing products—premium pricing, global reach, stellar safety\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003ePigeon dominates nursing bottles\/nipples (35% Japan, 22% China, nursing products = 28% of sales, ¥63.4bn in 2024), backed by \u0026gt;120 R\u0026amp;D scientists and 4–6 month time-to-market; global reach (70+ countries, ~45% revenue Asia‑Pacific) and top safety (recall \u0026lt;0.1%) support premium ASPs (+12% vs category) and \u0026gt;60% repeat purchases.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eJapan share\u003c\/td\u003e\n\u003ctd\u003e35%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eChina share\u003c\/td\u003e\n\u003ctd\u003e22%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNursing sales\u003c\/td\u003e\n\u003ctd\u003e¥63.4bn (28%)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNet sales\u003c\/td\u003e\n\u003ctd\u003e¥72.4bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRecall rate\u003c\/td\u003e\n\u003ctd\u003e\u0026lt;0.1%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eDelivers a strategic overview of Pigeon’s internal strengths and weaknesses alongside external opportunities and threats to clarify its competitive position and growth risks.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eDelivers a compact, visual SWOT layout that speeds alignment and decision-making across teams.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eW\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eeaknesses\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHeavy Revenue Concentration in China\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eA substantial share of Pigeon Corporation’s revenue—about 48% of consolidated sales and roughly 55% of operating profit in FY2024 (year ended March 31, 2024)—comes from China, creating concentrated geographic risk. A sudden shift in Chinese consumer sentiment against Japanese brands or tightened local import\/trade policies could cut sales sharply and hit margins. This lack of diversification makes Pigeon’s earnings highly sensitive to China's growth rate and policy cycles.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eVulnerability to Declining Domestic Birth Rates\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe persistent decline in Japan’s birth rate—1.26 births per woman in 2023 and 740,000 births in 2024, down ~3% vs 2020—directly shrinks Pigeon’s core infant-care market and reduces domestic unit demand.\u003c\/p\u003e\n\u003cp\u003eInternational sales eased revenue pressure (overseas sales ~50% of FY2024 revenue), but the shrinking home base forces Pigeon into costlier growth channels.\u003c\/p\u003e\n\u003cp\u003eThis demographic headwind demands frequent strategic pivots—product diversification, M\u0026amp;A, and greater R\u0026amp;D spending—to sustain historical growth rates.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLimited Diversification Beyond Infant Care\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003ePigeon's business remains highly concentrated in baby and maternity products, which represented about 85% of consolidated revenue in FY2024 (ended March 2024), exposing the firm to sector-specific downturns.\u003c\/p\u003e\n\u003cp\u003eUnlike larger consumer-health conglomerates with diversified portfolios, Pigeon lacks alternative revenue streams, limiting its ability to offset a prolonged stagnation in baby care.\u003c\/p\u003e\n\u003cp\u003eManagement is expanding into adjacent markets such as elderly care and home health, but those initiatives contributed under 5% of sales in FY2024 and have not reached scale to materially diversify risk.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eExposure to Raw Material Price Volatility\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eProduction of bottles, nipples, and skincare depends on petroleum-based plastics, silicone, and specialty chemicals; Brent crude rose ~40% from Jan 2023 to Jan 2025, increasing polymer feedstock costs and input inflation for Pigeon.\u003c\/p\u003e\n\u003cp\u003ePrice-sensitive parents limit pass-through; Indian retail infant-care inflation tolerance under 3% means higher costs squeeze margins unless Pigeon boosts procurement scale or shifts to bio-plastics.\u003c\/p\u003e\n\u003cp\u003eIf raw-material costs climb 10%, gross margin could compress ~150–250 basis points without efficiency gains; hedging and long-term contracts are key to protect margins.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eKey inputs: petroleum plastics, silicone, specialty chemicals\u003c\/li\u003e\n\u003cli\u003eBrent crude +40% (Jan 2023→Jan 2025)\u003c\/li\u003e\n\u003cli\u003e10% input rise → ~150–250 bps gross-margin hit\u003c\/li\u003e\n\u003cli\u003eLimited price pass-through; consumer sensitivity \u0026lt;3%\u003c\/li\u003e\n\u003cli\u003eMitigants: hedging, scale procurement, bio-plastics\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSlower Digital Transformation in Mature Markets\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003ePigeon lags behind digital-native rivals in advanced analytics and social commerce integration, slowing personalization and targeted ads; industry data shows social referrals drive 28% of baby-care purchases in the UK (2024) so this gap risks share loss.\u003c\/p\u003e\n\u003cp\u003eModernizing UX and backend systems requires heavy capex—estimated at $15–30m for a mid-size CPG digital overhaul—straining margins and slowing rollout across mature markets.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eSocial referrals ≈28% UK baby-care purchases (2024)\u003c\/li\u003e\n\u003cli\u003eEstimated digital overhaul capex $15–30m\u003c\/li\u003e\n\u003cli\u003eDelay → measurable share erosion vs digital natives\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eConcentrated China exposure, shrinking Japan market, input inflation \u0026amp; digital lag\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eGeographic concentration: China ~48% sales, ~55% OP profit (FY2024); policy\/brand risk. Demographics: Japan TFR 1.26 (2023), births 740k (2024) shrinking home market. Product concentration: baby\/maternity ~85% revenue (FY2024). Input inflation: Brent +40% (Jan2023–Jan2025); 10% input rise → ~150–250bps gross-margin hit. Digital lag: social referrals ~28% (UK 2024); estimated digital capex $15–30m.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eChina share\u003c\/td\u003e\n\u003ctd\u003e48% sales \/ 55% OP (FY2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eJapan births\u003c\/td\u003e\n\u003ctd\u003e740,000 (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCore revenue\u003c\/td\u003e\n\u003ctd\u003e85% baby\/maternity (FY2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBrent move\u003c\/td\u003e\n\u003ctd\u003e+40% (Jan2023–Jan2025)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMargin sensitivity\u003c\/td\u003e\n\u003ctd\u003e10% input ↑ → 150–250 bps\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003ePreview the Actual Deliverable\u003c\/span\u003e\u003cbr\u003ePigeon SWOT Analysis\u003c\/h2\u003e\n\u003cp\u003eThis is the actual Pigeon SWOT analysis document you’ll receive upon purchase—no surprises, just professional quality.\u003c\/p\u003e\n\u003cp\u003eThe preview below is taken directly from the full SWOT report you'll get; purchase unlocks the entire in-depth version.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56752722575737,"sku":"pigeon-swot-analysis","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/pigeon-swot-analysis.png?v=1772244377","url":"https:\/\/growthsharematrix.com\/products\/pigeon-swot-analysis","provider":"Growth Share Matrix","version":"1.0","type":"link"}